In Primary Myelofibrosis (PMF), megakaryocyte dysplasia/hyperplasia determines the release of inflammatory cytokines that, in turn, stimulate stromal cells and induce bone marrow fibrosis. The pathogenic mechanism and the cells responsible for progression to bone marrow fibrosis in PMF are not completely understood. This review article aims to provide an overview of the crucial role of megakaryocytes in myelofibrosis by discussing the role and the altered secretion of megakaryocyte-derived soluble factors, enzymes and extracellular matrices that are known to induce bone marrow fibrosis.
|Journal||Mediterranean Journal of Hematology and Infectious Diseases|
|Publication status||Published - Jan 1 2018|
- Bone marrow
- Myeloproliferative neoplasms
- Transforming growth factor-
ASJC Scopus subject areas
- Infectious Diseases